Showing 661 - 680 results of 74,577 for search '(( 20 a decrease ) OR ( 5 ((step decrease) OR (((we decrease) OR (nn decrease)))) ))', query time: 1.28s Refine Results
  1. 661

    Role of a Kinesin Motor in Cancer Cell Mechanics by Kalpana Mandal (320676)

    Published 2019
    “…Upon inhibition of KIF20A, cortical stiffness also decreases in lower grade cells, while it surprisingly increases in higher grade malignant cells. …”
  2. 662

    Role of a Kinesin Motor in Cancer Cell Mechanics by Kalpana Mandal (320676)

    Published 2019
    “…Upon inhibition of KIF20A, cortical stiffness also decreases in lower grade cells, while it surprisingly increases in higher grade malignant cells. …”
  3. 663

    Role of a Kinesin Motor in Cancer Cell Mechanics by Kalpana Mandal (320676)

    Published 2019
    “…Upon inhibition of KIF20A, cortical stiffness also decreases in lower grade cells, while it surprisingly increases in higher grade malignant cells. …”
  4. 664

    Rhodomyrtone decreases expression of inflammatory transcripts by TNF-α+IL-17A stimulated in skin organ cultures. by Julalak Chorachoo (5855852)

    Published 2018
    “…<p>Skin biopsies were pre-treated with 400 ng/ml rhodomyrtone 6 h before stimulation with 10 ng/ml TNF-α and 20 ng/ml IL-17A. Rhodomyrtone treatment decreases production of <i>DEFB4</i>, <i>IL1B</i>, <i>IL17C</i>, <i>IL36G</i>, <i>LCN2</i>, <i>PI3</i>, <i>S100A7</i>, and <i>S100A8</i> transcripts as measured by qRT-PCR at 72 h. …”
  5. 665
  6. 666
  7. 667
  8. 668

    Structure–Activity Studies of 1<i>H</i>‑Imidazo[4,5‑<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators by Lucas B. Fallot (14106171)

    Published 2022
    “…We previously reported 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amines as A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) positive allosteric modulators (PAMs). …”
  9. 669

    Structure–Activity Studies of 1<i>H</i>‑Imidazo[4,5‑<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators by Lucas B. Fallot (14106171)

    Published 2022
    “…We previously reported 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amines as A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) positive allosteric modulators (PAMs). …”
  10. 670
  11. 671

    Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub> by James R. Neilson (1896145)

    Published 2012
    “…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
  12. 672

    Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub> by James R. Neilson (1896145)

    Published 2012
    “…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
  13. 673

    Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub> by James R. Neilson (1896145)

    Published 2012
    “…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
  14. 674

    Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub> by James R. Neilson (1896145)

    Published 2012
    “…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
  15. 675

    Excel data file with all collected data. by Marcus Persson (20496333)

    Published 2025
    “…During the five-day treatment period and at a follow-up visit after 30 days we closely monitored adverse events and collected self-rated side effect data. …”
  16. 676
  17. 677
  18. 678
  19. 679
  20. 680

    The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

    Published 2017
    “…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”